首页> 外文期刊>Brazilian Archives of Biology and Technology >Homology modelling and insilico analysis of neuraminidase protein in H1N1 Influenza A virus
【24h】

Homology modelling and insilico analysis of neuraminidase protein in H1N1 Influenza A virus

机译:H1N1甲型流感病毒神经氨酸酶蛋白的同源性建模和计算机分析

获取原文
           

摘要

In this work, modelling of Neuraminidase protein of Influenza A virus (A/Himeji/1/2009(H1N1)) neuraminidase (NA) protein was done using Modeller 9V2. Modelled structure was submitted to protein model database and could be downloaded using accession number PM0075830. The modelled protein structure was subjected to In silco analysis using various bioinformatics tools. Two anti-influenza drugs currently being used to treat infected patients are oseltamivir (Tamiflu) and zanamivir (Relenza), both of which target the neuraminidase enzyme of the virus. Reports of the emergence of drug resistance make the development of new anti-influenza molecules a priority. Hence the modelled structure of H1NI Neuraminidase could be very useful for in silico analysis of potential neuraminidase inhibitors.
机译:在这项工作中,使用Modeller 9V2对A型流感病毒的神经氨酸酶蛋白(A / Himeji / 1/2009(H1N1))神经氨酸酶(NA)蛋白进行建模。建模的结构已提交到蛋白质模型数据库,可以使用登录号PM0075830下载。使用各种生物信息学工具对建模的蛋白质结构进行了硅化分析。当前用于治疗感染患者的两种抗流感药物是奥司他韦(Tamiflu)和扎那米韦(Relenza),两者均靶向该病毒的神经氨酸酶。有关耐药性出现的报道使开发新型抗流感分子成为当务之急。因此,H1NI神经氨酸酶的结构模型对于计算机分析潜在的神经氨酸酶抑制剂可能非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号